Cargando…
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis
INTRODUCTION: There are few drugs with proven efficacy in cutaneous leishmaniasis (CL), and pentavalent antimonial derivatives are still the main first-line therapeutic agents worldwide, despite their recognized high toxicities. Randomized controlled clinical trials assessing the efficacy and safety...
Autores principales: | Cota, Gláucia Fernandes, de Sousa, Marcos Roberto, Fereguetti, Tatiani Oliveira, Saleme, Priscila Said, Alvarisa, Thais Kawagoe, Rabello, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760744/ https://www.ncbi.nlm.nih.gov/pubmed/26894430 http://dx.doi.org/10.1371/journal.pone.0149697 |
Ejemplares similares
-
Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison
por: Cota, Gláucia F., et al.
Publicado: (2013) -
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017) -
Development and initial validation of a cutaneous leishmaniasis impact questionnaire
por: Galvão, Endi Lanza, et al.
Publicado: (2018) -
Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review
por: Cota, Gláucia F., et al.
Publicado: (2011) -
How cutaneous leishmaniasis and treatment impacts in the patients’ lives: A cross-sectional study
por: Galvão, Endi Lanza, et al.
Publicado: (2019)